Award
Delivery Order #SPE2DR26FL1MS
Delivery Order for Adenosine Pharmaceutical by AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$138.20
Ceiling
$138.20
Awarded
February 09, 2026
Period of Performance
Feb 09, 2026 – Feb 10, 2026
Identifier
SPE2DR26FL1MS
NAICS
424210
This award is a delivery order contract under a broader indefinite delivery vehicle held by AmerisourceBergen Drug Corp., a prominent pharmaceutical distribution and healthcare solutions company. The delivery order involves the procurement of Adenosine 6 mg/2 ml vials, a critical pharmaceutical product used in medical treatments. This specific contract ensures a prompt and focused supply of this essential medication to support agency health services. The work scope is narrowly focused on the delivery of these pharmaceutical vials, executed within a short, defined performance window in early 2026. The contract leverages an existing agreement, indicating a continuation of trusted supply relationships to maintain uninterrupted pharmaceutical provisions. Awarded through authorized delivery under the parent IDV contract, this order reflects an efficient procurement process aligned with agency medical readiness objectives.
Description
4570780274!ADENOSINE 6 MG/2 ML VIAL 2ML